Genetic studies indicate that a low level of MBOAT7 in a human liver cell increases the severity of NAFLD and an inactivating mutation increases the risk of fat accumulating in the liver [116]. Here, MBOAT7 is linked to metabolic dysfunction-associated steatotic liver disease.